Literature DB >> 1553971

Campylobacter peritonitis in continuous ambulatory peritoneal dialysis: report of eight cases and a review of the literature.

C J Wood1, V Fleming, J Turnidge, N Thomson, R C Atkins.   

Abstract

Continuous ambulatory peritoneal dialysis (CAPD)-associated peritonitis remains the most common complication of this form of renal replacement therapy and the potential causative organisms are many and varied. Campylobacter bacteria are unusual causes of peritonitis in CAPD patients and we report our experience with eight cases and review those cases reported in the literature. In many episodes, there is a strong association with acute enterocolitis, which may precede the onset of cloudy dialysate by many days. The method of spread of these organisms from the gastrointestinal tract to the peritoneal cavity remains speculative. Bacteremic transfer would appear the most likely route, although it is probable that no single mode of spread explains all episodes. The treatment of choice of Campylobacter peritonitis is with intraperitoneal aminoglycoside in combination with oral erythromycin. An awareness of the potential for Campylobacter to cause CAPD-associated peritonitis, particularly when diarrhea is a prominent feature, has resulted in this organism becoming increasingly isolated in our unit.

Entities:  

Mesh:

Year:  1992        PMID: 1553971     DOI: 10.1016/s0272-6386(13)80007-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Two cases of continuous ambulatory peritoneal dialysis-associated peritonitis due to Plesiomonas shigelloides.

Authors:  Patrick C Y Woo; Susanna K P Lau; Samson S Y Wong; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  Vibrio fluvialis peritonitis in a patient receiving continuous ambulatory peritoneal dialysis.

Authors:  Natasha Ratnaraja; Timothy Blackmore; Joan Byrne; Shuning Shi
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

3.  Campylobacter fetus peritonitis and bacteremia in a patient undergoing continuous ambulatory peritoneal dialysis.

Authors:  M P Romero Gómez; A García-Perea; G Ruiz Carrascoso; M A Bajo; J Mingorance
Journal:  J Clin Microbiol       Date:  2009-11-04       Impact factor: 5.948

4.  Evaluation of API Campy in comparison with conventional methods for identification of thermophilic campylobacters.

Authors:  M B Huysmans; J D Turnidge; J H Williams
Journal:  J Clin Microbiol       Date:  1995-12       Impact factor: 5.948

Review 5.  Clinical aspects of Campylobacter jejuni infections in adults.

Authors:  M C Peterson
Journal:  West J Med       Date:  1994-08

6.  Campylobacter peritonitis complicating peritoneal dialysis: a review of 12 consecutive cases.

Authors:  Terry King-wing Ma; Kin Ping Lee; Kai Ming Chow; Wing Fai Pang; Bonnie Ching Ha Kwan; Chi Bon Leung; Cheuk Chun Szeto; Philip Kam-tao Li
Journal:  Perit Dial Int       Date:  2012-10-02       Impact factor: 1.756

Review 7.  ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment.

Authors:  Philip Kam-Tao Li; Cheuk Chun Szeto; Beth Piraino; Javier de Arteaga; Stanley Fan; Ana E Figueiredo; Douglas N Fish; Eric Goffin; Yong-Lim Kim; William Salzer; Dirk G Struijk; Isaac Teitelbaum; David W Johnson
Journal:  Perit Dial Int       Date:  2016-06-09       Impact factor: 1.756

8.  Serum Sphingosine-1-phosphate level and peritonitis in peritoneal dialysis patients.

Authors:  Qiong Bai; Hong-Xia Guo; Chun-Yan Su; Qing-Feng Han; Tao Wang; Wen Tang
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.